female androgenetic alopecia
Conditions
Interventions
Experimental Group:compound Platycladus orientalis tincture combined with Seaport Rolling Needle and Suspended Gentle Moxibustion
Control Group:compound Platycladus orientalis tincture
Sponsors
Shanghai Dermatology Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1: Capable of understanding and signing the informed consent form independently; 2: The participant is willing and able to complete all steps of the study and the intervention period; 3: Female, aged between 18 and 55 years; 4: Good general health, meeting the diagnostic criteria for spleen-stomach damp-heat type female androgenetic alopecia in both traditional Chinese and Western medicine; 5: Able to accept topical drug treatment and willing to adhere to the study intervention protocol; 6: For women of childbearing potential: Use of highly effective contraceptive measures for at least 1 month prior to screening, and agreement to continue using such measures for 1 month after the study intervention ends; 7: Compliance with all lifestyle during the entire study period.
Exclusion criteria
Exclusion criteria: 1: Pregnant or breastfeeding women; 2: Individuals who have undergone local or systemic AGA treatment within the past 3 months; 3: Individuals with a history of hair transplantation; those currently undergoing chemotherapy or radiotherapy; 4: Individuals allergic to roller needle materials, prone to needle fainting, or unable to tolerate roller needle treatment; 5: Individuals with active skin diseases, skin tumors, skin infections, or keloid-prone skin on the scalp; 6: Presence of malignant tumors or tumors of unknown nature in the treatment area; 7: Individuals suffering from mental disorders, coagulation disorders, or other hematological diseases; 8: Individuals with impaired liver or kidney function, or those taking hepatotoxic medications during treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hair shaft diametervariation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| hair number;hair density;Clinical symptom score;Clinical efficacy score;dampness-heat of spleen and stomach syndrome score; | — |
Countries
China
Contacts
Public ContactYan Qiang
Shanghai Dermatology Hospital
Outcome results
None listed